Logo-apb
Adv Pharm Bull. 2025;15(1): 162-175. doi: 10.34172/apb.43672

Original Article

A Novel GLP-1 and FGF21 Fusion Protein for the Treatment of Non-alcoholic Steatohepatitis (NASH)

Zhipeng Zhang 1,2 ORCID, Yanqin Ma 2, Cheng Xie 2, Yan He 2, Dong Wang 2, Huaien Song 2, Miao Yuan 3, Xiaomei Zhang 1 * ORCID

Cited by CrossRef: